Of the 34 genes, NOS3, ADK, ACE, AGT and PIK3CB were identified as being druggable targets37 (Supplementary Table 5), however the impact of therapeutics on the risk of cardiovascular disease associated with SARS-CoV-2 remains unknown. This evidence concerns the gene NOS3 and cardiovascular disorder.